Scientists at Penn State have caught a cancer-linked protein breaking one of biology's house rules. Using cryo-electron microscopy, the team captured BRD4 bound to an entire nucleosome, the spool-like structure that packages DNA into chromosomes. The near-atomic-resolution images showed BRD4 latching on in ways researchers did not expect, including a grip on the chromosome that works without the chemical tag textbooks say the protein needs. The findings appear in the journal Molecular Cell, according to the university.

BRD4 belongs to a family of proteins that carry structures called bromodomains. It uses them to bind chromosomes, where it helps control when other genes are switched on or off. The protein plays a role in how cells read, copy and repair DNA, and in how different cell types are made. It has been linked to many kinds of cancer, which makes it a promising target for future therapies, the researchers said.

BRD4 is one of the most studied members of its family, because its misbehavior shows up across so many cancers. Bromodomain proteins act as readers that interpret chemical marks on chromosomes, and drug developers already have BRD4 in their sights. That is why structural biologists care about the fine details of its grip: a drug designed to interfere with BRD4 needs to know exactly which part of the protein touches what.

The rule everyone thought BRD4 followed

The old model was simple. Researchers believed BRD4 gripped the nucleosome only when its bromodomains met histone proteins carrying a chemical modification, an acetylation tag. Without the tag, the thinking went, the protein could not hold on. Earlier studies had only ever shown BRD4 attached to a fragment of a single modified histone, so the full picture was missing.

Song Tan, a molecular biology professor at Penn State who led the research, wanted to see the interaction in its natural setting. His team imaged BRD4 bound to a complete nucleosome instead of a fragment. Co-first authors Jiang Zhu, an assistant research professor, and Erik Leith, who recently finished his doctorate at Penn State, ran the imaging with technologists Erin O'Donnell and Bryan Manzano and assistant professor Jean-Paul Armache. Shwu-Yuan Wu and Cheng-Ming Chiang of the University of Texas Southwestern Medical Center rounded out the team.

Cryo-electron microscopy made this view possible. The technique flash-freezes molecules and photographs them at near-atomic resolution, letting researchers build three-dimensional maps of proteins caught in the act. Without it, BRD4's extra contacts with DNA would likely have stayed hidden.

What the 3D images revealed

The structure confirmed one expectation and overturned another. BRD4 bound the modified histone as predicted. But it also gripped the nucleosome's DNA directly, a contact nobody had seen before. And when one of BRD4's bromodomains latched onto a modified histone, the protein's shape formed a flat surface where other proteins could dock. Zhu said the shape looked like the protein was rolling out a welcome mat for its interaction partners.

Then came the bigger surprise. Follow-up experiments stripped the acetylation tags off the histones, and BRD4 held on with nearly the same strength anyway. It was long-standing dogma in the field that the acetylation tag was needed to recruit the bromodomain to nucleosomes, Leith said, adding that the result caught the team off guard. The researchers do not yet know whether this tag-free binding happens inside living cells. If it does, it could reveal new settings where BRD4 and related bromodomain proteins do their work.

Why cancer researchers are paying attention

Knowing exactly how BRD4 grips chromosomes could shape the next generation of therapies aimed at it. Tan said the team's goal was to understand BRD4's basic biology, and that a clearer picture of its structure and function could yield clues for building more effective treatments. The university announced the findings on September 14, and Phys.org reported on the study the same week.

The next question is whether the tag-free grip shows up in living cells. The team plans to probe that, because the answer decides whether drug designers need to account for a second binding mode. Either way, the study changes the starting assumption for anyone working on bromodomain proteins: the tag matters less than textbooks assumed.

There are limits to what the study shows. Structures captured in the lab do not always play out the same way inside cells, and the researchers are upfront about that open question. But if tag-free binding turns out to be real in living tissue, it would rewrite the binding rules for an entire protein family. The full results appear in Molecular Cell in a paper titled "BRD4 binds the nucleosome via both histone and DNA interactions."